title: Cytomegalovirus Retinitis in a Patient Who Received Ruxolitinib.
authors.affiliation: Hallands Hospital Halmstad, Halmstad, Sweden joanna.vonhofsten@regionhalland.se.
authors.forename: Joanna
authors.initials: J
authors.lastname: von Hofsten
authors.forename: Marianne
authors.initials: M
authors.lastname: Johnsson Forsberg
authors.forename: Madeleine
authors.initials: M
authors.lastname: Zetterberg
mesh_terms: D000368:Aged; D003587:Cytomegalovirus / Q000302:isolation & purification; D017726:Cytomegalovirus Retinitis / Q000139:chemically induced*; D006801:Humans; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D008297:Male; D009570:Nitriles; D009894:Opportunistic Infections / Q000139:chemically induced*; D055728:Primary Myelofibrosis / Q000188:drug therapy; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines
chemical_list: D009570:Nitriles; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases